Barnes J, Johnson S J, French J J
Newcastle upon Tyne Hospitals NHS Foundation Trust , UK.
Ann R Coll Surg Engl. 2017 Mar;99(3):193-197. doi: 10.1308/rcsann.2016.0225. Epub 2016 Aug 4.
INTRODUCTION Neuroendocrine tumours (NETs) are a heterogeneous group of tumours with a highly variable presentation and prognosis. Management decisions are complex. Ki-67 levels in tissue samples are a key indicator used to grade tumours and guide treatment. This study assessed whether the Ki-67 index and tumour grade generated from tissue samples correlated with that assessed in resection specimens. METHODS This was a retrospective cohort analysis of all patients who had both a tissue sample and a resection specimen analysed in our trust, a tertiary referral centre, during 2012 and 2013. RESULTS Data from 36 patients were reviewed. Ki-67 indices from tissue samples and resection specimens showed strong correlation (r=0.95, p<0.001). Tumour grading was the same in the tissue sample and resection specimens for 22 patients (61.1%). In four patients (11.1%), the tissue sample overestimated the grade while in ten (27.8%), the sample underestimated the grade. CONCLUSIONS In most cases, the Ki-67 index and tumour grade from the tissue sample matched that of the resection specimen. However, in nearly 40% of cases, the tissue sample grading did not match the resection tumour grading. In the majority of these, the tissue sample underestimated disease activity. A low Ki-67 index in a tissue sample should therefore be taken as provisional and should not, in isolation, persuade clinicians to choose a more conservative treatment approach if there is clinical, biochemical or radiological evidence suggestive of a more aggressive disease pathology.
神经内分泌肿瘤(NETs)是一组异质性肿瘤,其临床表现和预后差异很大。治疗决策复杂。组织样本中的Ki-67水平是用于肿瘤分级和指导治疗的关键指标。本研究评估了组织样本中的Ki-67指数和肿瘤分级与切除标本中评估的结果是否相关。
这是一项回顾性队列分析,研究对象为2012年至2013年期间在我们医院(一家三级转诊中心)接受组织样本和切除标本分析的所有患者。
对36例患者的数据进行了回顾。组织样本和切除标本的Ki-67指数显示出强烈相关性(r=0.95,p<0.001)。22例患者(61.1%)的组织样本和切除标本中的肿瘤分级相同。4例患者(11.1%)的组织样本高估了分级,10例患者(27.8%)的样本低估了分级。
在大多数情况下,组织样本中的Ki-67指数和肿瘤分级与切除标本中的相符。然而,在近40%的病例中,组织样本分级与切除肿瘤分级不匹配。在大多数此类病例中,组织样本低估了疾病活动度。因此,如果有临床、生化或放射学证据提示疾病病理更具侵袭性,组织样本中低Ki-67指数应视为初步结果,不应仅凭此说服临床医生选择更保守的治疗方法。